BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY

Clinical trials for BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY trials appear

Sign up with your email to follow new studies for BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for tough pancreatic tumors: scientists test stronger Radiation-Chemo combo

Disease control Ongoing

This early-stage study is testing a new treatment combination for pancreatic cancer that cannot be easily removed by surgery. Doctors are carefully increasing the doses of a chemotherapy drug (nab-paclitaxel) and radiation therapy together to see if it can better control the tumo…

Matched conditions: BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY

Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY

Get alerted when new BORDERLINE RESECTABLE PANCREATIC CANCER TREATED WITH CHEMORADIOTHERAPY trials appear

New hope for tough pancreatic tumors: scientists test stronger Radiation-Chemo combo